Menu
19/11/2019
QUB Shares In £1.25m Cancer Research Funding
Queen's University Belfast is to share in £1.25 million of funding to further prostate cancer research.
The money was awarded to local academics and those at The University of Manchester by Prostate Cancer UK and Movember.
It will be used to expand clinical trials, develop and pioneer novel treatments while enhancing expert knowledge of the aggressive cancer that affects one in eight men.
The funding follows a £5m investment from Prostate Cancer UK and Movember in 2014 to create the first regional Movember Centre of Excellence, a partnership between the two universities.
Prostate cancer is the most common cancer among males in the UK, with more than 47,500 new diagnoses every year.
Since the initiative (known as FASTMAN) began, researchers have developed new tests to identify high risk patients, and find which patients respond best to various treatment options.
Joe O'Sullivan, Professor of Radiation Oncology at the Centre for Cancer Research and Cell Biology at QUB, said recent developments include new tests to identify types of tumour and greater understandings of how radiotherapy can be used as a treatment.
He explained: "Through these new tests, we can potentially identify patients with particularly high risk prostate cancer to determine what treatment will be most effective, tailored to the particular tumour.
"We have also tested several new treatment options through clinical trials which have had encouraging results. We are currently planning to expand availability of these trials to eligible men across the nation. We are proud of the real successes to date and we are delighted to be able to continue this important work."
Simon Grieveson, Head of Research Funding at Prostate Cancer UK said: "Prostate cancer is the most commonly diagnosed cancer in men in the UK and sadly thousands of men die from this disease each year. There is still so much we don't know about this disease, and so investment into research is crucial if we are to improve the way prostate cancer is diagnosed and treated.
"Over the past five years the Belfast-Manchester Movember Centre of Excellence has brought together some of the world's leading researchers and clinicians, who have made huge strides in the investigation of new treatments and tests to help tackle prostate cancer.
"Which is why Prostate Cancer UK and Movember have extended our initial £5 million funding of the centre by an additional £1.25 million, so that the team can expand their work and continue to help us answer some of the most important questions in prostate cancer research."
The Bishop of Connor, the Rt Rev Alan Abernethy, was diagnosed with aggressive prostate cancer during a sabbatical in 2018, aged 62. Bishop Abernethy was asked to take part in the clinical trial led by Professor O'Sullivan and his team that used a new combination of existing cancer therapies for men with advanced prostate cancer. Bishop Abernethy recently completed his treatment when he also announced his retirement. He said: "The trial has given me the most amazing gift – the best possible treatment. I'm delighted that this trial is set to continue so that many more people can receive this treatment."
(JG/MH)
The money was awarded to local academics and those at The University of Manchester by Prostate Cancer UK and Movember.
It will be used to expand clinical trials, develop and pioneer novel treatments while enhancing expert knowledge of the aggressive cancer that affects one in eight men.
The funding follows a £5m investment from Prostate Cancer UK and Movember in 2014 to create the first regional Movember Centre of Excellence, a partnership between the two universities.
Prostate cancer is the most common cancer among males in the UK, with more than 47,500 new diagnoses every year.
Since the initiative (known as FASTMAN) began, researchers have developed new tests to identify high risk patients, and find which patients respond best to various treatment options.
Joe O'Sullivan, Professor of Radiation Oncology at the Centre for Cancer Research and Cell Biology at QUB, said recent developments include new tests to identify types of tumour and greater understandings of how radiotherapy can be used as a treatment.
He explained: "Through these new tests, we can potentially identify patients with particularly high risk prostate cancer to determine what treatment will be most effective, tailored to the particular tumour.
"We have also tested several new treatment options through clinical trials which have had encouraging results. We are currently planning to expand availability of these trials to eligible men across the nation. We are proud of the real successes to date and we are delighted to be able to continue this important work."
Simon Grieveson, Head of Research Funding at Prostate Cancer UK said: "Prostate cancer is the most commonly diagnosed cancer in men in the UK and sadly thousands of men die from this disease each year. There is still so much we don't know about this disease, and so investment into research is crucial if we are to improve the way prostate cancer is diagnosed and treated.
"Over the past five years the Belfast-Manchester Movember Centre of Excellence has brought together some of the world's leading researchers and clinicians, who have made huge strides in the investigation of new treatments and tests to help tackle prostate cancer.
"Which is why Prostate Cancer UK and Movember have extended our initial £5 million funding of the centre by an additional £1.25 million, so that the team can expand their work and continue to help us answer some of the most important questions in prostate cancer research."
The Bishop of Connor, the Rt Rev Alan Abernethy, was diagnosed with aggressive prostate cancer during a sabbatical in 2018, aged 62. Bishop Abernethy was asked to take part in the clinical trial led by Professor O'Sullivan and his team that used a new combination of existing cancer therapies for men with advanced prostate cancer. Bishop Abernethy recently completed his treatment when he also announced his retirement. He said: "The trial has given me the most amazing gift – the best possible treatment. I'm delighted that this trial is set to continue so that many more people can receive this treatment."
(JG/MH)
Related Northern Ireland News Stories
Click here for the latest headlines.
25 November 2024
Visit Belfast Celebrates 25 Years of Transforming Tourism Landscape
Visit Belfast, the city's dedicated Destination Marketing and Management Organisation (DMMO), is celebrating a quarter-century of success.
Visit Belfast Celebrates 25 Years of Transforming Tourism Landscape
Visit Belfast, the city's dedicated Destination Marketing and Management Organisation (DMMO), is celebrating a quarter-century of success.
21 November 2024
5 New Trends Sweeping The Online Gaming Industry
Online gaming is constantly changing. Each year, new trends emerge that shape the experiences of millions of players worldwide. This year is no different, with several exciting shifts capturing the attention of gamers everywhere.
5 New Trends Sweeping The Online Gaming Industry
Online gaming is constantly changing. Each year, new trends emerge that shape the experiences of millions of players worldwide. This year is no different, with several exciting shifts capturing the attention of gamers everywhere.
19 November 2024
Seating Matters To Create 62 New Jobs In £3.7m Investment
Economy Minister Conor Murphy has announced a significant investment by Seating Matters, a leading global manufacturer of therapeutic seating solutions. The company will invest £3.7 million in its facilities in Limavady and Derry, creating 62 new jobs over the next two years.
Seating Matters To Create 62 New Jobs In £3.7m Investment
Economy Minister Conor Murphy has announced a significant investment by Seating Matters, a leading global manufacturer of therapeutic seating solutions. The company will invest £3.7 million in its facilities in Limavady and Derry, creating 62 new jobs over the next two years.
18 November 2024
Belfast's Vacant To Vibrant Scheme To Expand Citywide
A successful scheme aimed at transforming vacant properties in Belfast city centre into thriving businesses is set to be extended across the entire city. Belfast City Council's Vacant to Vibrant programme has already breathed new life into 26 properties, with another six sites in the pipeline.
Belfast's Vacant To Vibrant Scheme To Expand Citywide
A successful scheme aimed at transforming vacant properties in Belfast city centre into thriving businesses is set to be extended across the entire city. Belfast City Council's Vacant to Vibrant programme has already breathed new life into 26 properties, with another six sites in the pipeline.
15 November 2024
Belfast City Council Approves Range Of Transformative Projects
Belfast City Council's Planning Committee has given the green light to a series of projects aimed at transforming the city's landscape. One significant development is the redevelopment of the former police station at 21 Queen Street into a 74-bedroom hotel.
Belfast City Council Approves Range Of Transformative Projects
Belfast City Council's Planning Committee has given the green light to a series of projects aimed at transforming the city's landscape. One significant development is the redevelopment of the former police station at 21 Queen Street into a 74-bedroom hotel.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
